Cipla Limited is a global pharmaceutical company founded in 1935 and headquartered in Mumbai, India. Cipla markets 1500+ products across major therapeutic areas and operates 46–47 manufacturing facilities worldwide, selling into 86 countries with a workforce of 30,000.
As part of its digital transformation agenda, Cipla needed a secure, efficient, and compliant system for managing user access across its vast enterprise ecosystem, a challenge addressed through AmpleLogic’s UMS solution.
Summary
Cipla partnered with AmpleLogic to implement its User Management System (UMS), replacing legacy manual user management with a fully automated, centralized digital platform.
The UMS rollout now spans 15+ sites across India with plans to expand into China, and currently supports 18,000+ active users. The system integrates with SAP SuccessFactors and Active Directory (AD), while thousands of legacy records were migrated into the Cipla UMS system to ensure continuity and compliance.
Challenges
- Manual User Access Requests: Provisioning and deprovisioning of users relied on manual processes, resulting in inefficiencies, delays, and frequent errors.
- Scalability Concerns: Managing access across multiple sites and thousands of employees created bottlenecks.
- Audit & Compliance Risks: Incomplete visibility and a lack of audit trails complicated regulatory inspections.
- Time-Consuming Workflows: Coordination between IT, HR, and functional managers slowed approvals.
- Fragmented Legacy Data: Historical records were dispersed across systems, making tracking and reporting difficult.
Solutions Implemented
- All access requests are routed through UMS (single, centralized request and approval application).
- Manual user management is fully automated via the UMS platform.
- Integration with SAP SuccessFactors for all the user details.
- Active Directory (AD) integration for enterprise authentication and access enforcement.
- Legacy data migration: Thousands of historical user records were uploaded into Cipla’s UMS.
- Multi-site deployment: Implemented across 15+ Indian sites, with expansion to China planned.
- At-scale operations: 18,000+ active users currently using the application.
Results / Benefits
- Manual challenges eliminated, saving significant time for IT and end-users.
- System supports 18,000+ active users across 15+ sites, with capacity for global expansion.
- Centralized digital access management with full audit trails ensures inspection readiness.
- Self-service requests and electronic approvals accelerate access provisioning.
- Consistent workflows across sites reduce errors and compliance risks.
- The system is designed to expand globally, with the China rollout in progress.
Why Cipla Chose AmpleLogic?
Cipla selected AmpleLogic for its:
- Pharma compliance expertise with built-in audit trails and regulatory alignment.
- Configurable workflows that adapt to complex user hierarchies without custom coding.
- Integration capabilities with HR, IT, and enterprise applications.
- Proven scalability demonstrated across multi-site deployments.
AmpleLogic’s UMS platform provided Cipla with a future-ready, scalable solution that strengthened security, improved efficiency, and ensured regulatory compliance across its enterprise operations.
Ready to Transform Your User Access Management?
Discover how AmpleLogic can streamline your user lifecycle, strengthen compliance, and scale with your enterprise. Request a Demo Today.
